From:  Treatment of malignant diseases with phytocannabinoids: promising observations in animal models and patients

Pancreatic cancer treatment with cannabinoids

DiseaseTreatmentPatient(s)ResultsRef.
Pancreatic cancer (advanced, metastatic disease)pure CBD, 400 mg per day, concomitant to standard chemotherapy (2 patients with CBD as the only treatment)

9 patients; mean age at diagnose 49.7 years (range 45–70 years);

5 women, 4 men

The mean overall survival was 11.5 months (median 11 months) and seems to be longer than the overall survival reported in the literature for metastatic disease (5.9 months)[132]